Incidence and Risk Factors of Pulmonary Vein Stenosis Following Heart Transplantation in Children
Overview
This study reports an 18% incidence of de novo pulmonary vein stenosis (PVS) in pediatric heart transplant recipients, primarily associated with congenital heart disease (CHD). The findings highlight the need for targeted surveillance in high-risk groups.
Background
Pulmonary vein stenosis (PVS) is a serious complication following pediatric heart transplantation, potentially leading to pulmonary hypertension and graft dysfunction. Understanding the incidence and risk factors for PVS is crucial for improving outcomes in this vulnerable population. Current literature indicates that CHD is a significant predictor of PVS, but long-term data remain limited.
Data Highlights
Parameter
Value
Incidence of PVS
18%
Median time to diagnosis
84 days
Significant association with CHD
p = 0.007
Significant association with PHM
p = 0.017
Male-to-female donor-recipient mismatch
p = 0.035
Key Findings
PVS developed in 18% of pediatric heart transplant recipients.
Median time to diagnosis of PVS was 84 days post-transplant.
Congenital heart disease (CHD) was the only significant predictor of PVS in multivariate analysis (p = 0.015).
Donor-recipient size mismatch parameters were greater among patients with PVS.
PVS did not significantly affect overall survival probability (p = 0.240).
Clinical Implications
Clinicians should be vigilant for signs of PVS in pediatric heart transplant recipients, especially those with congenital heart disease. Implementing a structured surveillance strategy may help in early detection and management of this complication.
Conclusion
The study underscores the importance of identifying high-risk groups for pulmonary vein stenosis following heart transplantation in children. Further research is needed to validate these findings in larger cohorts.
In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.
